— Know what they know.
/
Not Investment Advice
Also trades as: 0I3Q.L (LSE) · $vol 0M

CORT NASDAQ

Corcept Therapeutics Incorporated
1W: -22.3% 1M: -24.9% 3M: -7.5% YTD: +128.1% 1Y: +19.4% 3Y: +211.2% 5Y: +359.6%
$87.59
+0.47 (+0.53%)
After Hours: $86.07 (-1.52, -1.74%)
Weekly Expected Move ±11.6%
$66 $76 $86 $96 $106
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 39 · $9.4B mcap · 96M float · 1.25% daily turnover · Short 52% of daily vol
Credit Risk of going bust: lower than 85% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Corcept Therapeutics Incorporated would be worth roughly what it owes.
Total debt $9.4M against a stock market value of $9.42B.
Distance to default 11.18 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $5.7M (short-term plus half of long-term), stock volatility 64.9%; Altman Z'' 8.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 3.1%  ·  5Y Avg: 50.3%
Cost Advantage
59
Intangibles
67
Switching Cost
38
Network Effect
65
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CORT has a Narrow competitive edge (59.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 3.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$150
Low
$160
Avg Target
$165
High
Based on 3 analysts since Jul 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 9Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$159.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-18 Truist Financial Srikripa Devarakonda $50 $164 +114 +40.0% $117.17
2026-07-30 H.C. Wainwright Swayampakula Ramakanth $95 $165 +70 +77.5% $92.95
2026-07-29 Canaccord Genuity Edward Nash $100 $150 +50 +59.3% $94.19
2026-07-27 Wolfe Research — $30 $50 +20 -47.6% $95.36
2026-06-02 H.C. Wainwright Swayampakula Ramakanth $75 $95 +20 +34.9% $70.44
2026-05-28 UBS — $72 $135 +63 +102.6% $66.65
2026-05-13 UBS — $95 $72 -23 +40.7% $51.16
2026-05-04 H.C. Wainwright — $67 $75 +8 +45.9% $51.42
2026-05-01 Piper Sandler — $38 $88 +50 +89.2% $46.52
2026-02-20 H.C. Wainwright — $105 $67 -38 +95.7% $34.24
2026-01-23 Canaccord Genuity — $99 $100 +1 +142.1% $41.30
2026-01-22 H.C. Wainwright Swayampakula Ramakanth $90 $105 +15 +153.2% $41.47
2026-01-02 H.C. Wainwright Swayampakula Ramakanth $145 $90 -55 +147.6% $36.35
2026-01-02 Canaccord Genuity Edward Nash $140 $99 -41 +168.3% $36.90
2025-12-31 Truist Financial — $135 $50 -85 +46.0% $34.25
2025-12-31 Wolfe Research — Initiated $30 — -9.4% $33.12
2025-12-16 UBS Ashwani Verma Initiated $95 — +8.8% $87.30
2025-09-10 Canaccord Genuity — $78 $140 +62 +95.5% $71.62
2025-05-06 Truist Financial Joon Lee $76 $135 +59 +90.8% $70.74
2025-05-06 H.C. Wainwright Swayampakula Ramakanth $80 $145 +65 +96.1% $73.94
2024-10-18 H.C. Wainwright Swayampakula Ramakanth $45 $80 +35 +69.6% $47.17
2024-09-30 Truist Financial Joon Lee $65 $76 +11 +73.0% $43.93
2024-08-15 Canaccord Genuity Edward Nash $38 $78 +40 +124.7% $34.71
2024-07-30 Piper Sandler David Amsellem $35 $38 +3 +5.2% $36.12
2024-07-30 H.C. Wainwright Swayampakula Ramakanth $40 $45 +5 +23.2% $36.53
2024-06-12 Canaccord Genuity Edward Nash Initiated $38 — +15.9% $32.79
2024-06-10 Piper Sandler David Amsellem Initiated $35 — +11.1% $31.51
2024-06-04 Truist Financial Joon Lee Initiated $65 — +105.8% $31.59
2024-05-02 H.C. Wainwright Swayampakula Ramakanth $30 $40 +10 +67.5% $23.88
2022-12-09 H.C. Wainwright — $33 $30 -3 +30.4% $23.01
2022-08-04 H.C. Wainwright — Initiated $33 — +14.9% $28.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
4
ROE
3
ROA
4
D/E
4
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CORT receives an overall rating of B. Strongest factors: DCF (4/5), ROA (4/5), D/E (4/5). Areas of concern: P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-21 B+ B
2026-10-16 B B+
2026-10-14 B+ B
2026-10-12 B B+
2026-10-01 B+ B
2026-08-28 B B+
2026-08-20 B+ B
2026-08-14 B B+
2026-07-01 B+ B
2026-06-01 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 57 Grade A
Profitability
56
Balance Sheet
98
Earnings Quality
78
Growth
34
Value
32
Momentum
65
Safety
100
Cash Flow
64
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CORT scores highest in Safety (100/100) and lowest in Value (32/100). An overall grade of A places CORT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
36.21
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.57
Unlikely Manipulator
Ohlson O-Score
-9.92
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 93.7/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 2.01x
Accruals: -6.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CORT scores 36.21, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CORT scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CORT's score of -2.57 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CORT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CORT receives an estimated rating of AA+ (score: 93.7/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CORT's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
168.01x
PEG
-2.86x
P/S
11.37x
P/B
13.04x
P/FCF
96.27x
P/OCF
93.83x
EV/EBITDA
347.17x
EV/Revenue
12.03x
EV/EBIT
379.04x
EV/FCF
93.48x
Earnings Yield
0.53%
FCF Yield
1.04%
Shareholder Yield
0.93%
Graham Number
$7.86
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 168.0x earnings, CORT is priced for high growth expectations. Graham's intrinsic value formula yields $7.86 per share, 1008% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.070
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
0.032
EBIT / Rev
×
Asset Turnover
0.983
Rev / Assets
×
Equity Multiplier
1.260
Assets / Equity
=
ROE
8.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CORT's ROE of 8.1% is driven by Asset Turnover (0.983), indicating efficient use of assets to generate revenue. A tax burden ratio of 2.07 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$3.92
Price/Value
22.19x
Margin of Safety
-2118.53%
Premium
2118.53%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CORT's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CORT trades at a 2119% premium to its adjusted intrinsic value of $3.92, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 168.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$87.59
Median 1Y
$92.24
5th Pctile
$30.64
95th Pctile
$278.03
Ann. Volatility
66.8%
Analyst Target
$159.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joseph K. Belanoff,
M.D., Chief Executive Officer and President
 $1,182,333 $— $15,303,551
Charles Robb, Business
siness Officer and Secretary
 $711,413 $124,500 $6,380,500
William Guyer, Pharm.D.,
Chief Development Officer
 $706,387 $17,871 $6,340,445
Sean Maduck, Corcept
nt Corcept Endocrinology
 $648,860 $111,995 $6,208,642
Atabak Mokari, Financial
ancial Officer and Treasurer
 $566,347 $97,733 $6,135,667

CEO Pay Ratio

25:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $15,303,551
Avg Employee Cost (SGA/emp): $614,692
Employees: 730

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
730
+46.0% YoY
Revenue / Employee
$1,043,023
Rev: $761,407,000
Profit / Employee
$136,510
NI: $99,652,000
SGA / Employee
$614,692
Avg labor cost proxy
R&D / Employee
$349,189
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 20.7% 25.0% 24.4% 23.4% 23.1% 23.1% 20.2% 21.9% 19.5% 21.0% 21.9% 24.8% 25.7% 23.7% 21.6% 21.5% 16.6% 14.9% 7.2% 8.1% 8.14%
ROA 19.0% 22.6% 21.9% 21.2% 20.9% 20.1% 17.4% 18.5% 16.2% 17.6% 18.5% 20.3% 20.5% 19.2% 17.7% 17.5% 13.1% 11.8% 5.7% 6.5% 6.46%
ROIC 58.8% 73.3% 1.7% 1.5% 1.5% 1.4% 1.4% 1.5% 75.0% 65.9% 74.3% 83.6% 46.1% 39.5% 29.7% 36.0% 33.3% 21.7% -8.6% 3.1% 3.15%
ROCE 21.9% 33.1% 32.0% 29.3% 26.4% 22.0% 18.7% 22.9% 20.8% 20.8% 21.8% 21.8% 22.7% 20.4% 16.6% 15.5% 10.8% 8.2% 1.1% 3.6% 3.59%
Gross Margin 98.7% 98.6% 98.7% 98.7% 98.7% 98.6% 98.7% 98.7% 98.7% 98.6% 98.3% 98.5% 98.4% 98.4% 98.5% 98.2% 97.8% 98.7% 98.3% 98.4% 98.41%
Operating Margin 37.7% 37.1% 28.6% 30.4% 31.4% 21.8% 14.1% 25.1% 25.2% 23.4% 20.1% 21.7% 25.5% 13.9% 2.2% 13.7% 4.9% 2.2% -30.1% 16.1% 16.12%
Net Margin 31.7% 32.4% 24.3% 26.5% 34.0% 16.1% 15.0% 23.4% 25.4% 23.2% 18.9% 21.7% 25.6% 16.7% 12.9% 18.1% 9.3% 12.0% -18.9% 16.5% 16.45%
EBITDA Margin 38.5% 37.9% 29.4% 31.0% 32.1% 22.6% 14.3% 25.4% 25.5% 23.8% 20.2% 25.6% 25.8% 14.1% 2.5% 14.0% 7.6% 5.1% -26.8% 18.3% 18.27%
FCF Margin 43.3% 45.7% 46.6% 38.6% 34.2% 29.8% 26.7% 31.5% 34.3% 26.3% 23.8% 21.6% 22.7% 29.0% 25.8% 25.2% 21.9% 18.6% 15.6% 12.9% 12.87%
OCF Margin 43.5% 45.9% 46.7% 38.6% 34.3% 29.9% 26.8% 31.6% 34.3% 26.3% 23.8% 21.7% 23.0% 29.3% 26.2% 25.4% 22.0% 18.6% 15.6% 13.2% 13.20%
ROE 3Y Avg snapshot only 16.57%
ROE 5Y Avg snapshot only 19.53%
ROA 3Y Avg snapshot only 13.43%
ROIC 3Y Avg snapshot only 56.53%
ROIC Economic snapshot only 1.84%
Cash ROA snapshot only 12.34%
Cash ROIC snapshot only 26.95%
CROIC snapshot only 26.27%
NOPAT Margin snapshot only 1.54%
Pretax Margin snapshot only 3.17%
R&D / Revenue snapshot only 30.56%
SGA / Revenue snapshot only 66.98%
SBC / Revenue snapshot only -1.36%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 23.13 21.55 23.16 24.34 25.59 23.30 26.46 25.77 33.13 33.93 23.46 28.69 37.25 42.54 103.01 66.74 94.37 42.10 88.45 188.58 168.007
P/S Ratio 6.98 6.62 6.81 7.00 7.52 5.88 6.04 5.70 6.73 7.47 5.29 6.35 8.37 8.84 19.97 12.35 13.39 5.48 5.47 12.39 11.367
P/B Ratio 4.56 6.45 6.35 6.20 6.32 4.71 4.72 5.78 6.56 7.11 5.05 6.06 8.24 8.78 20.03 13.91 15.71 6.44 6.60 14.58 13.044
P/FCF 16.13 14.48 14.61 18.15 22.00 19.70 22.60 18.09 19.61 28.38 22.20 29.32 36.91 30.47 77.25 49.06 61.06 29.42 35.14 96.27 96.273
P/OCF 16.04 14.44 14.58 18.12 21.93 19.64 22.52 18.02 19.59 28.35 22.18 29.21 36.38 30.14 76.27 48.54 60.96 29.37 35.05 93.83 93.834
EV/EBITDA 17.35 17.26 16.68 17.72 19.99 16.71 19.73 20.56 26.79 29.74 19.14 23.28 32.42 38.76 112.78 81.93 131.25 66.60 424.69 347.17 347.174
EV/Revenue 5.96 6.01 5.91 6.06 6.53 4.81 4.92 4.85 5.94 6.70 4.50 5.52 7.78 8.29 19.51 11.88 12.83 5.00 5.05 12.03 12.030
EV/EBIT 17.77 17.68 17.08 18.13 20.47 17.15 20.21 20.99 27.24 30.14 19.34 23.49 32.74 39.12 114.40 83.45 134.73 68.87 545.65 379.04 379.036
EV/FCF 13.77 13.15 12.67 15.72 19.10 16.11 18.40 15.40 17.31 25.48 18.91 25.53 34.29 28.55 75.47 47.19 58.51 26.84 32.40 93.48 93.478
Earnings Yield 4.3% 4.6% 4.3% 4.1% 3.9% 4.3% 3.8% 3.9% 3.0% 2.9% 4.3% 3.5% 2.7% 2.4% 1.0% 1.5% 1.1% 2.4% 1.1% 0.5% 0.53%
FCF Yield 6.2% 6.9% 6.8% 5.5% 4.5% 5.1% 4.4% 5.5% 5.1% 3.5% 4.5% 3.4% 2.7% 3.3% 1.3% 2.0% 1.6% 3.4% 2.8% 1.0% 1.04%
Price/Tangible Book snapshot only 14.585
EV/OCF snapshot only 91.110
EV/Gross Profit snapshot only 12.238
Acquirers Multiple snapshot only 1560.468
Shareholder Yield snapshot only 0.93%
Graham Number snapshot only $7.86
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 8.98 5.60 6.78 8.54 8.52 6.89 6.77 4.65 3.54 4.39 5.18 5.57 3.70 3.35 3.07 3.06 3.14 2.92 2.86 2.86 2.859
Quick Ratio 8.87 5.50 6.69 8.43 8.41 6.80 6.69 4.57 3.48 4.31 5.10 5.48 3.64 3.26 2.96 2.98 3.07 2.85 2.77 2.77 2.773
Debt/Equity 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.013
Net Debt/Equity -0.67 -0.59 -0.84 -0.83 -0.83 -0.86 -0.88 -0.86 -0.77 -0.73 -0.75 -0.78 -0.58 -0.55 -0.46 -0.53 -0.66 -0.57 -0.51 -0.42 -0.423
Debt/Assets 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.011
Debt/EBITDA 0.01 0.00 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.04 0.05 0.05 0.06 0.06 0.09 0.11 1.05 0.33 0.327
Net Debt/EBITDA -2.97 -1.75 -2.54 -2.74 -3.04 -3.72 -4.50 -3.59 -3.56 -3.38 -3.33 -3.46 -2.48 -2.61 -2.66 -3.23 -5.73 -6.41 -35.95 -10.38 -10.378
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.08 1.13 1.15 1.12 1.13 1.16 1.17 1.24 1.29 1.23 1.20 1.20 1.23 1.24 1.24 1.26 1.30 1.29 1.28 1.26 1.259
Cash Ratio snapshot only 2.004
Cash to Debt snapshot only 32.714
FCF to Debt snapshot only 11.349
Defensive Interval snapshot only 173.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.63 0.74 0.75 0.74 0.71 0.80 0.76 0.84 0.80 0.80 0.82 0.92 0.91 0.92 0.91 0.94 0.92 0.91 0.93 0.98 0.983
Inventory Turnover 1.06 1.07 1.05 1.03 0.95 0.97 0.96 0.94 0.90 0.94 1.12 1.12 1.26 1.08 1.00 1.13 1.31 1.03 0.99 1.11 1.106
Receivables Turnover 14.56 13.60 15.40 14.06 14.22 13.70 13.86 14.10 14.05 13.37 11.13 13.19 13.32 14.20 11.12 12.10 11.46 13.39 15.25 11.74 11.744
Payables Turnover 0.79 0.60 0.65 0.60 0.71 0.57 0.54 0.71 0.49 0.44 0.64 0.62 0.56 0.66 0.53 0.54 0.50 0.46 0.44 0.73 0.733
DSO 25 27 24 26 26 27 26 26 26 27 33 28 27 26 33 30 32 27 24 31 31.1 days
DIO 346 342 348 355 383 376 380 390 407 389 325 325 290 338 366 323 278 356 370 330 329.9 days
DPO 460 603 563 613 511 640 677 512 746 827 569 584 657 550 688 673 723 785 831 498 498.0 days
Cash Conversion Cycle -90 -235 -192 -232 -103 -238 -271 -96 -314 -410 -211 -232 -340 -186 -289 -320 -413 -402 -437 -137 -137.0 days
Fixed Asset Turnover snapshot only 69.275
Operating Cycle snapshot only 361.0 days
Cash Velocity snapshot only 2.696
Capital Intensity snapshot only 1.070
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -0.9% 3.4% 11.8% 14.3% 12.7% 9.8% 8.8% 9.2% 13.2% 20.0% 26.5% 33.0% 39.7% 39.9% 30.9% 25.7% 17.9% 12.8% 12.2% 16.0% 16.02%
Net Income -2.7% 6.1% 12.5% 15.5% 9.8% -9.9% -15.5% -16.1% -21.8% 4.7% 24.9% 33.2% 54.6% 32.2% 12.6% 5.2% -25.6% -29.4% -64.2% -58.8% -58.81%
EPS -3.2% 10.5% 26.8% 26.8% 17.8% -5.1% -15.8% -11.6% -17.9% 9.8% 31.2% 31.2% 51.0% 23.8% 3.3% -2.9% -29.1% -30.2% -58.9% -58.1% -58.08%
FCF -7.1% 11.1% 24.2% 12.9% -11.0% -28.4% -37.6% -10.8% 13.6% 5.8% 12.7% -8.5% -7.6% 54.4% 42.1% 46.2% 14.0% -27.6% -32.4% -40.7% -40.69%
EBITDA -10.2% -2.2% 19.8% 22.6% 7.2% -9.4% -23.4% -24.7% -23.2% -5.9% 19.4% 33.9% 51.2% 32.7% -3.8% -23.2% -52.0% -60.4% -92.3% -72.3% -72.28%
Op. Income -10.8% -2.9% 19.5% 22.7% 7.2% -9.5% -23.5% -24.6% -22.6% -4.8% 21.1% 29.4% 46.1% 27.7% -9.1% -20.3% -54.3% -67.3% -1.1% -93.7% -93.72%
OCF Growth snapshot only -39.79%
Asset Growth snapshot only 10.85%
Equity Growth snapshot only 11.01%
Debt Growth snapshot only 42.63%
Shares Change snapshot only -1.74%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 14.1% 13.4% 13.7% 13.5% 11.7% 9.5% 7.3% 6.8% 8.1% 10.9% 15.5% 18.4% 21.2% 22.6% 21.7% 22.2% 23.1% 23.7% 22.9% 24.7% 24.73%
Revenue 5Y 37.2% 35.1% 32.6% 29.2% 25.1% 20.3% 16.9% 14.7% 13.6% 13.9% 15.2% 16.2% 17.1% 17.1% 15.4% 15.3% 15.8% 16.6% 17.7% 19.3% 19.35%
EPS 3Y -10.9% 15.1% 16.5% 15.0% 12.0% 4.3% -1.9% -2.3% -2.2% 4.8% 11.9% 13.7% 13.5% 8.8% 4.5% 4.0% -4.2% -1.8% -17.7% -18.9% -18.87%
EPS 5Y 85.6% 66.4% 56.5% 37.8% 28.9% -3.0% -6.0% -5.7% -7.3% 9.7% 11.8% 12.0% 11.7% 9.1% 5.0% 3.5% 0.0% -0.1% -9.9% -9.8% -9.76%
Net Income 3Y -11.1% 14.3% 13.6% 13.0% 10.4% 2.5% -3.7% -6.1% -5.8% 0.0% 5.9% 8.9% 9.9% 7.6% 5.9% 5.5% -3.5% -0.8% -20.4% -16.8% -16.75%
Net Income 5Y 88.3% 69.1% 54.9% 36.0% 27.0% -4.7% -7.8% -8.5% -9.6% 7.1% 9.1% 10.0% 10.2% 8.3% 4.6% 3.0% -0.8% -1.3% -13.7% -11.0% -10.97%
EBITDA 3Y 11.9% 12.4% 15.2% 13.1% 8.0% 0.5% -8.0% -11.0% -9.6% -5.9% 3.1% 7.3% 7.6% 4.2% -4.2% -8.2% -17.7% -20.9% -55.4% -34.2% -34.18%
EBITDA 5Y 77.3% 65.5% 56.4% 39.2% 29.1% 16.9% 8.3% 5.5% 2.9% 3.9% 6.9% 7.9% 7.9% 4.9% -2.2% -6.2% -11.7% -15.2% -39.5% -23.4% -23.44%
Gross Profit 3Y 14.3% 13.6% 14.0% 13.7% 11.9% 9.6% 7.5% 7.0% 8.2% 11.0% 15.5% 18.4% 21.2% 22.6% 21.6% 22.1% 22.9% 23.6% 22.8% 24.6% 24.58%
Gross Profit 5Y 37.6% 35.4% 32.9% 29.5% 25.4% 20.6% 17.1% 14.8% 13.8% 14.1% 15.3% 16.4% 17.2% 17.2% 15.5% 15.3% 15.7% 16.5% 17.7% 19.3% 19.30%
Op. Income 3Y 11.1% 11.6% 14.6% 12.8% 7.7% 0.3% -8.2% -11.2% -9.6% -5.8% 3.5% 6.2% 6.6% 3.2% -5.6% -8.0% -19.7% -26.5% — -59.8% -59.84%
Op. Income 5Y 76.9% 65.0% 55.8% 38.6% 28.5% 16.3% 7.8% 5.1% 2.6% 3.7% 6.9% 6.9% 7.2% 4.2% -3.2% -6.3% -13.2% -19.0% — -43.0% -43.04%
FCF 3Y 8.7% 13.2% 19.3% 9.7% 7.9% -3.9% -8.6% -8.0% -2.1% -5.6% -4.4% -2.7% -2.3% 5.4% -0.0% 6.0% 6.2% 5.7% 2.7% -7.4% -7.43%
FCF 5Y 53.6% 55.9% 48.7% 31.7% 27.6% 14.7% 5.3% 9.6% 5.4% 1.9% 3.6% 1.5% 5.7% 7.7% 4.1% 0.8% -0.2% -1.2% -3.5% -4.4% -4.40%
OCF 3Y 8.9% 13.2% 19.2% 9.5% 7.7% -4.0% -8.7% -7.9% -2.2% -5.8% -4.7% -2.9% -2.0% 5.7% 0.3% 6.4% 6.1% 5.7% 2.6% -6.7% -6.75%
OCF 5Y 53.6% 55.6% 48.4% 31.4% 27.4% 14.6% 5.3% 9.6% 5.4% 1.9% 3.5% 1.4% 5.8% 7.8% 4.3% 1.0% -0.3% -1.3% -3.6% -4.1% -4.10%
Assets 3Y 25.0% 10.8% 13.5% 14.7% 13.3% 12.3% 11.5% 1.8% 3.6% 2.8% 5.9% 7.9% 10.2% 25.6% 21.8% 17.3% 15.6% 12.8% 9.7% 19.2% 19.21%
Assets 5Y 56.2% 43.9% 44.1% 41.8% 37.0% 21.5% 20.5% 13.8% 14.7% 14.8% 15.4% 16.8% 16.4% 15.3% 13.7% 10.0% 9.0% 7.9% 8.1% 9.3% 9.35%
Equity 3Y 27.7% 10.9% 12.6% 14.1% 12.3% 10.6% 9.0% -2.4% -1.9% -1.1% 2.4% 4.5% 5.7% 21.8% 18.8% 12.9% 10.1% 8.9% 6.4% 18.7% 18.74%
Book Value 3Y 28.0% 11.7% 15.4% 16.1% 13.9% 12.6% 11.1% 1.5% 1.8% 3.6% 8.2% 9.1% 9.2% 23.2% 17.2% 11.2% 9.2% 7.8% 10.0% 15.7% 15.72%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.94 0.94 0.92 0.92 0.92 0.93 0.93 0.93 0.95 0.96 0.94 0.90 0.85 0.82 0.82 0.82 0.85 0.88 0.93 0.94 0.943
Earnings Stability 0.44 0.35 0.23 0.18 0.17 0.00 0.11 0.16 0.24 0.54 0.46 0.38 0.39 0.54 0.45 0.32 0.03 0.04 0.10 0.06 0.056
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.999
Rev. Growth Consistency 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.99 0.98 0.95 0.94 0.96 0.96 0.94 0.94 0.91 0.98 0.90 0.87 0.50 0.87 0.95 0.98 0.90 0.88 0.50 0.50 0.500
Earnings Smoothness 0.97 0.94 0.88 0.86 0.91 0.90 0.83 0.83 0.76 0.95 0.78 0.72 0.57 0.72 0.88 0.95 0.71 0.66 0.06 0.17 0.167
ROE Trend -0.04 0.07 0.05 0.04 0.04 -0.05 -0.06 0.00 -0.02 -0.04 -0.01 -0.03 -0.00 0.00 -0.00 -0.01 -0.04 -0.06 -0.13 -0.13 -0.133
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.001
FCF Margin Trend 0.01 0.02 0.04 -0.06 -0.11 -0.14 -0.18 -0.07 -0.04 -0.11 -0.13 -0.13 -0.12 0.01 0.01 -0.01 -0.07 -0.09 -0.09 -0.11 -0.105
Sustainable Growth Rate 20.7% 25.0% 24.4% 23.4% 23.1% 23.1% 20.2% 21.9% 19.5% 21.0% 21.9% 24.8% 25.7% 23.7% 21.6% 21.5% 16.6% 14.9% 7.2% 8.1% 8.14%
Internal Growth Rate 23.5% 29.2% 28.1% 26.9% 26.4% 25.2% 21.1% 22.8% 19.4% 21.4% 22.7% 25.5% 25.8% 23.8% 21.5% 21.2% 15.1% 13.4% 6.1% 6.9% 6.90%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.44 1.49 1.59 1.34 1.17 1.19 1.17 1.43 1.69 1.20 1.06 0.98 1.02 1.41 1.35 1.37 1.55 1.43 2.52 2.01 2.010
FCF/OCF 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 1.00 0.97 0.975
FCF/Net Income snapshot only 1.959
OCF/EBITDA snapshot only 3.810
CapEx/Revenue 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.1% 0.3% 0.3% 0.3% 0.3% 0.0% 0.0% 0.0% 0.3% 0.33%
CapEx/Depreciation snapshot only 1.148
Accruals Ratio -0.08 -0.11 -0.13 -0.07 -0.03 -0.04 -0.03 -0.08 -0.11 -0.03 -0.01 0.00 -0.00 -0.08 -0.06 -0.07 -0.07 -0.05 -0.09 -0.07 -0.065
Sloan Accruals snapshot only -0.018
Cash Flow Adequacy snapshot only 39.475
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 92.2% 2.6% 2.3% 2.1% 1.8% 0.0% 0.0% 1.5% 1.6% 1.4% 1.2% 2.8% 10.7% 10.8% 11.4% 86.6% 1.4% 1.8% 3.9% 1.8% 1.76%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 4.0% 12.2% 10.1% 8.5% 6.9% 0.0% 0.0% 6.0% 4.8% 4.0% 5.3% 0.1% 0.3% 0.3% 0.1% 1.3% 1.5% 4.4% 4.5% 0.9% 0.93%
Net Buyback Yield 4.0% 12.2% 10.1% 8.5% 6.9% 0.0% 0.0% 5.9% 4.8% 4.0% 5.2% 0.0% 0.2% 0.2% 0.1% 1.1% 1.3% 4.0% 3.9% 0.7% 0.74%
Total Shareholder Return 4.0% 12.2% 10.1% 8.5% 6.9% 0.0% 0.0% 5.9% 4.8% 4.0% 5.2% 0.0% 0.2% 0.2% 0.1% 1.1% 1.3% 4.0% 3.9% 0.7% 0.74%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.89 0.90 0.85 0.85 0.91 0.87 0.88 0.87 0.82 0.85 0.84 0.84 0.85 0.87 0.98 1.05 1.19 1.49 3.92 2.07 2.070
Interest Burden (EBT/EBIT) 1.01 1.00 1.00 1.01 1.01 1.03 1.07 1.10 1.14 1.16 1.16 1.12 1.11 1.13 1.16 1.24 1.25 1.20 1.71 1.00 1.000
EBIT Margin 0.34 0.34 0.35 0.33 0.32 0.28 0.24 0.23 0.22 0.22 0.23 0.24 0.24 0.21 0.17 0.14 0.10 0.07 0.01 0.03 0.032
Asset Turnover 0.63 0.74 0.75 0.74 0.71 0.80 0.76 0.84 0.80 0.80 0.82 0.92 0.91 0.92 0.91 0.94 0.92 0.91 0.93 0.98 0.983
Equity Multiplier 1.09 1.11 1.11 1.10 1.10 1.15 1.16 1.18 1.21 1.19 1.18 1.22 1.25 1.23 1.22 1.23 1.27 1.26 1.26 1.26 1.260
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.85 $0.92 $0.97 $0.98 $1.00 $0.87 $0.82 $0.86 $0.82 $0.96 $1.07 $1.13 $1.24 $1.18 $1.11 $1.10 $0.88 $0.83 $0.46 $0.46 $0.46
Book Value/Share $4.32 $3.07 $3.55 $3.83 $4.06 $4.31 $4.59 $3.85 $4.16 $4.57 $4.98 $5.36 $5.62 $5.74 $5.70 $5.28 $5.29 $5.40 $6.11 $5.96 $6.70
Tangible Book/Share $4.32 $3.07 $3.55 $3.83 $4.06 $4.31 $4.59 $3.85 $4.16 $4.57 $4.98 $5.36 $5.62 $5.74 $5.70 $5.28 $5.29 $5.40 $6.11 $5.96 $5.96
Revenue/Share $2.82 $2.99 $3.31 $3.40 $3.41 $3.45 $3.59 $3.91 $4.05 $4.35 $4.76 $5.12 $5.53 $5.70 $5.72 $5.94 $6.21 $6.35 $7.36 $7.02 $7.88
FCF/Share $1.22 $1.37 $1.54 $1.31 $1.17 $1.03 $0.96 $1.23 $1.39 $1.14 $1.13 $1.11 $1.25 $1.65 $1.48 $1.50 $1.36 $1.18 $1.15 $0.90 $1.01
OCF/Share $1.23 $1.37 $1.54 $1.31 $1.17 $1.03 $0.96 $1.23 $1.39 $1.15 $1.14 $1.11 $1.27 $1.67 $1.50 $1.51 $1.36 $1.18 $1.15 $0.93 $1.04
Cash/Share $2.89 $1.83 $3.00 $3.21 $3.40 $3.71 $4.03 $3.31 $3.20 $3.32 $3.74 $4.25 $3.34 $3.24 $2.69 $2.84 $3.53 $3.11 $3.24 $2.60 $2.92
EBITDA/Share $0.97 $1.04 $1.17 $1.16 $1.11 $0.99 $0.89 $0.92 $0.90 $0.98 $1.12 $1.22 $1.33 $1.22 $0.99 $0.86 $0.61 $0.48 $0.09 $0.24 $0.24
Debt/Share $0.01 $0.00 $0.02 $0.02 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.05 $0.06 $0.06 $0.06 $0.05 $0.05 $0.05 $0.09 $0.08 $0.08
Net Debt/Share $-2.88 $-1.82 $-2.98 $-3.19 $-3.38 $-3.70 $-4.02 $-3.31 $-3.20 $-3.32 $-3.74 $-4.20 $-3.28 $-3.18 $-2.64 $-2.79 $-3.48 $-3.05 $-3.15 $-2.52 $-2.52
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 36.213
Altman Z-Prime snapshot only 63.796
Piotroski F-Score 5 8 7 7 7 5 5 6 6 8 7 5 6 5 5 4 5 6 5 6 6
Beneish M-Score -2.05 -2.57 -3.12 -3.02 -2.78 -2.29 -2.05 -2.28 -2.09 -2.04 -1.87 -2.11 -1.97 -2.42 -2.05 -2.13 -2.78 -2.78 -3.48 -2.57 -2.570
Ohlson O-Score snapshot only -9.925
ROIC (Greenblatt) snapshot only 8.85%
Net-Net WC snapshot only $2.17
EVA snapshot only $-27880041.15
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 93.20 93.41 93.11 93.83 93.92 93.50 93.13 93.37 93.49 93.30 93.39 93.81 93.73 94.02 93.70 93.85 93.34 93.36 78.33 93.71 93.706
Credit Grade snapshot only 2
Credit Trend snapshot only -0.145
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 90
Sector Credit Rank snapshot only 90

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms